STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 75 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,876,000 | +15.7% | 1,595,082 | 0.0% | 0.18% | -25.3% |
| Q3 2020 | $3,350,000 | +93.1% | 1,595,082 | +247.5% | 0.24% | +76.3% |
| Q2 2020 | $1,735,000 | -0.1% | 458,971 | -50.0% | 0.14% | +36.3% |
| Q1 2020 | $1,736,000 | +36.4% | 917,942 | +50.7% | 0.10% | -30.1% |
| Q4 2019 | $1,273,000 | -42.3% | 608,971 | -34.1% | 0.15% | -40.7% |
| Q3 2019 | $2,208,000 | -23.6% | 923,700 | 0.0% | 0.25% | -6.5% |
| Q2 2019 | $2,891,000 | -31.6% | 923,700 | +8.8% | 0.26% | -31.3% |
| Q1 2019 | $4,227,000 | +11.2% | 848,700 | 0.0% | 0.38% | +66.5% |
| Q4 2018 | $3,802,000 | +161.5% | 848,700 | +183.2% | 0.23% | +144.7% |
| Q3 2018 | $1,454,000 | -3.1% | 299,700 | +19.9% | 0.09% | -6.9% |
| Q2 2018 | $1,500,000 | -32.2% | 250,000 | 0.0% | 0.10% | -48.5% |
| Q1 2018 | $2,213,000 | +52.6% | 250,000 | +25.0% | 0.20% | +60.7% |
| Q4 2017 | $1,450,000 | – | 200,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |